The abstract is read at the publisher; the summary is JClub's.
An end-to-end fully cell-free system for 1,2,4-butanetriol biosynthesis scaled from 10 µL to 1 L, achieving ~1 g/L/h volumetric productivity and >13 g BT.
- Why it matters: Cell-free pathway prototyping can speed enzyme optimization, but it has rarely been demonstrated as scalable manufacturing, limiting progress toward practical in vitro production.
- What they did: The workflow screened ~150 enzymes across the four-step xylose-to-BT pathway, then used statistical Design of Experiments to optimize formulations for cost and titer.
- The result: Scaling the maximum-titer and minimum-cost formulations across five orders of magnitude produced ~1 g/L/h and titers over 13 g in a single 1 L reaction, with $3.00 per liter reagent costs.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.